Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | RGNX REGENXBIO | Stock Options Common Stock | Grant | Acquire A | No | No | 7.86 | 62,547 | 491.62 k | 62,547 |
16 Sep 24 | RGNX REGENXBIO | Common Stock | Grant | Acquire A | No | No | 0 | 58,869 | 0.00 | 58,869 |
16 Sep 24 | RGNX REGENXBIO | Stock Options Common Stock | Grant | Acquire A | No | No | 12.74 | 289,362 | 3.69 mm | 289,362 |
13 Aug 24 | AVTX Avalo Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 9,500 | 0.00 | 9,500 |
13 Aug 24 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 9.88 | 24,600 | 243.05 k | 24,600 |
20 Dec 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.043 | 3,334 | 143.36 | 3,334 |